

IBD DriveTime: Manasi Agrawal, MD, on First-Line Resection for Crohn's Disease
Jan 2, 2024
Dr Manasi Agrawal discusses her research into surgery as a first-line therapy for Crohn's disease, comparing outcomes and highlighting the importance of real-world data. The study found that illuscular section had lower hazards and consistent results in favor of it. The speaker explores the misconception that surgery is a failure of gastroenterology, highlighting its potential as a viable option for patients with Crohn's disease. Challenges and the need for more research in outcomes research are discussed.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Comparing outcomes of early ICR and anti-TNF for limited Crohn's disease
02:03 • 4min
Primary and Secondary Outcomes of Illuscular Section vs. Anti TNF Therapy in Crohn's Disease
05:57 • 4min
Strengths, Limitations, and Clinical Implications of a Study on Ileocecal Resection for Crohn's Disease
10:02 • 5min
Exploring Surgical Options and Challenges in Crohn's Disease Management
15:07 • 6min